A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus

Summary

This was a 52-week, multicenter, non-randomized, open-label, Phase 3 long-term safety study in participants with type 2 diabetes mellitus who have inadequate glycemic control with monotherapy of oral antihyperglycemic medication (OAM).

Timeline

Start

2011-11

Primary completion

2013-12

Completion

2013-12

Drugs

Indications